Young ME, Marchase RB, Chatham JC. Stromal interaction molecule 1 is essential for normal cardiac homeostasis through modulation of ER and mitochondrial function. Am J Physiol Heart Circ Physiol 306: H1231-H1239, 2014. First published February 28, 2014 doi:10.1152/ajpheart.00075.2014.-The endoplasmic reticulum (ER) Ca 2ϩ sensor stromal interaction molecule 1 (STIM1) has been implicated as a key mediator of store-dependent and store-independent Ca 2ϩ entry pathways and maintenance of ER structure. STIM1 is present in embryonic, neonatal, and adult cardiomyocytes and has been strongly implicated in hypertrophic signaling; however, the physiological role of STIM1 in the adult heart remains unknown. We, therefore, developed a novel cardiomyocyte-restricted STIM1 knockout ( cr STIM1-KO) mouse. In cardiomyocytes isolated from cr STIM1-KO mice, STIM1 expression was reduced by ϳ92% with no change in the expression of related store-operated Ca 2ϩ entry proteins, STIM2, and Orai1. Immunoblot analyses revealed that cr STIM1-KO hearts exhibited increased ER stress from 12 wk, as indicated by increased levels of the transcription factor C/EBP homologous protein (CHOP), one of the terminal markers of ER stress. Transmission electron microscopy revealed ER dilatation, mitochondrial disorganization, and increased numbers of smaller mitochondria in cr S-TIM1-KO hearts, which was associated with increased mitochondrial fission. Using serial echocardiography and histological analyses, we observed a progressive decline in cardiac function in cr STIM1-KO mice, starting at 20 wk of age, which was associated with marked left ventricular dilatation by 36 wk. In addition, we observed the presence of an inflammatory infiltrate and evidence of cardiac fibrosis from 20 wk in cr STIM1-KO mice, which progressively worsened by 36 wk. These data demonstrate for the first time that STIM1 plays an essential role in normal cardiac function in the adult heart, which may be important for the regulation of ER and mitochondrial function. store-operated Ca 2ϩ entry; STIM1; cardiomyocytes; ER stress; mitochondria
STIM1-KO mice, STIM1 expression was reduced by ϳ92% with no change in the expression of related store-operated Ca 2ϩ entry proteins, STIM2, and Orai1. Immunoblot analyses revealed that cr STIM1-KO hearts exhibited increased ER stress from 12 wk, as indicated by increased levels of the transcription factor C/EBP homologous protein (CHOP), one of the terminal markers of ER stress. Transmission electron microscopy revealed ER dilatation, mitochondrial disorganization, and increased numbers of smaller mitochondria in cr S-TIM1-KO hearts, which was associated with increased mitochondrial fission. Using serial echocardiography and histological analyses, we observed a progressive decline in cardiac function in cr STIM1-KO mice, starting at 20 wk of age, which was associated with marked left ventricular dilatation by 36 wk. In addition, we observed the presence of an inflammatory infiltrate and evidence of cardiac fibrosis from 20 wk in cr STIM1-KO mice, which progressively worsened by 36 wk. These data demonstrate for the first time that STIM1 plays an essential role in normal cardiac function in the adult heart, which may be important for the regulation of ER and mitochondrial function. store-operated Ca 2ϩ entry; STIM1; cardiomyocytes; ER stress; mitochondria MAINTENANCE OF Ca 2ϩ homeostasis is critical for normal cellular function and response to stress. This is especially important in the heart, where precise control of Ca 2ϩ is essential for excitation-contraction coupling as well as Ca 2ϩ -mediated signaling. In cardiomyocytes it is generally accepted that voltagedependent Ca 2ϩ channels function as the predominant pathway for Ca 2ϩ entry across the sarcolemma, leading to subsequent Ca 2ϩ -induced Ca 2ϩ release from the endoplasmic reticulum/ sarcoplasmic reticulum (ER/SR), which is responsible for normal excitation-contraction coupling (1) . Ca 2ϩ release from the ER/SR induced by inositol 1,4,5-trisphosphate (IP 3 )-generating agonists also occurs in the heart, although its role in cardiomyocyte Ca 2ϩ homeostasis still remains relatively understudied (1) . However, Marchase and colleagues (18) demonstrated that in neonatal cardiomyocytes, IP 3 -induced activation of hypertrophic signaling, characterized by calcineurin-mediated nuclear factor of activated T-cell nuclear translocation, was dependent on an influx of extracellular Ca 2ϩ that was independent of voltage-gated Ca 2ϩ pathways. This type of Ca 2ϩ entry, termed store-operated Ca 2ϩ entry (SOCE), was first identified in the 1970s and is widely accepted as the primary mechanism for Ca 2ϩ signaling in nonexcitable cells. However, understanding the regulation of SOCE and its wider acceptance in excitable cells, such as cardiomyocytes, was hampered for many years by the lack of identification of the molecular mediators of the pathway. This changed dramatically in 2005 with the identification of stromal interaction molecule 1 (STIM1) as the ER/SR Ca 2ϩ sensor responsible for the activation of SOCE (33, 43) .
STIM1 is a ubiquitously expressed type-I membrane protein, with its NH 2 -terminus including a canonical EF-hand Ca 2ϩ binding domain located in the ER/SR lumen. The COOHterminal region, which extends into the cytosol, contains a number of key regulatory domains that play a role in facilitating SOCE (5). In the currently accepted model for STIM1-mediated SOCE, a decrease in ER Ca 2ϩ results in dissociation of Ca 2ϩ from STIM1, facilitating STIM1 oligomerization and subsequent accumulation of STIM1 in ER-plasma membrane junctions, where it interacts with Orai1 leading to Ca 2ϩ entry (21, 33) . While there are several variations of this model, the STIM1-Orai1 interaction is fundamental to the molecular mechanism of SOCE, and the knockdown of STIM1 attenuates SOCE (20, 22, 33, 38) .
Although we and others have shown that both SOCE and STIM1/Orai1 exist in embryonic, neonatal, and adult cardiomyocytes (18, 30, 35, 42) , it should be noted that the role of SOCE in adult cardiomyocytes remains controversial. Interestingly, while three separate groups have recently reported that STIM1 appears to be an essential component of the pathogenesis of cardiac hypertrophy (17, 22, 38) , whether this is primarily through activation of SOCE remains to be determined. Importantly, there are also some store-independent functions of STIM1, including regulation of arachidonic acidregulated Ca 2ϩ (ARC) channels (36) and the maintenance of ER/SR structure (11).
Since STIM1 is highly conserved and appears to be ubiquitous in all eukaryotic cells (6) , it seems likely that in addition to its pathophysiological role, STIM1 may also play an important physiological role in the heart; however, to date, remarkably little is known of the physiological role of STIM1 in the adult heart. Ubiquitous germ-line deletion of STIM1 is embryonically lethal (27) ; therefore, to determine the physiological role of STIM1 in the heart, we generated a cardiomyocyterestricted STIM1 knockout ( cr STIM1-KO) mouse. We found that as early as 12 wk of age, there is evidence of ER stress and mitochondrial abnormalities in cr STIM1-KO hearts; between 20 and 36 wk of age, cr STIM1-KO mice exhibit a progressive decline in left ventricular (LV) function with the development of a dilated cardiomyopathy. This study demonstrates for the first time that STIM1 is essential for normal cardiomyocyte homeostasis potentially through maintenance of ER/SR and mitochondrial function. cr STIM1-KO mice were generated through breeding of homozygous STIM1 flox/flox mice, in which exon 2 of STIM1 was flanked by 2 lox P sites (28) with cardiomyocyte-specific ␣-MHC-cre; all mice were on a C57/B6 background. At 21 days of age, mice were weaned, tail-snipped, and ear-tagged, and genomic DNA was extracted from tail snips using a Qiagen Gentra Puregene kit. PCR was performed using genomic DNA obtained from tail snips, and as previously described, primer pairs were used to confirm STIM1 genotype (23) and expression of the ␣-MHC-cre transgene (26) .
MATERIALS AND METHODS

Materials
Adult cardiomyocytes were isolated from 20-wk control and cr STIM1-KO mice, as previously described (24, 25, 34) .
Assessment of in vivo cardiac function. As previously described (41), mice were initially anesthetized using 5% isoflurane-95% O 2 and restrained on a heated pad where chest hair was removed and a rectal temperature probe was inserted to ensure maintenance of body temperature. For measurements of cardiac function, the level of isoflurane was adjusted to 1.8%, and heart rate was continually assessed to ensure that cardiac function was not significantly depressed. Serial echocardiography was performed every 4 wk on adult male control and cr STIM1-KO mice between 12 and 36 wk of age using a Visualsonics Vevo 770 system in combination with a 30-Mhz transducer.
Tissue analyses. For histological analyses, hearts were perfused from the apex with ice-cold PBS containing 25 mM KCl to clear blood and to arrest the heart. Hearts were then extracted, cut into transverse or longitudinal sections, and fixed for 24 h in 10% neutral buffered formalin and embedded in paraffin. Sections were cut at 5 m and stained with hematoxylin-eosin, Masson trichrome, and picric acid Sirius red to assess cardiac morphology, cardiac fibrosis, and collagen deposition, respectively.
For transmission electron microscopy, LV tissue was isolated into longitudinal sections and placed in 0.1 mol/l cacodylate buffer containing 2% glutaldehyde-paraformaldehyde and was heat-fixed for 30 min to cross link proteins and aldehydes. Lipid fixation was performed using 2% osmium tetroxide in 0.1 mol/l cacodylate buffer and 1% aqueous uranyl acetate and tissue embedded in Epon. Transmission electron microscopy was performed at the UAB high-resolution imaging facility, and longitudinal sections of tissue were assessed at the level of the ER/SR membrane, mitochondria, and contractile filaments.
To determine changes in protein levels, whole heart tissue or cardiomyocytes were initially homogenized/sonicated in lysis buffer containing 20 mM HEPES, 1.5 mM MgCl 2, 20 mM KCl, 20% glycerol, 0.2 mM EGTA, 1% Triton X-100, 2 mM Na3VO4, 10 mM NaF, and 2% protease inhibitor (pH 7.9). Protein was quantified using a Bio-Rad DC assay, and lysates were prepared using 6ϫ sample buffer, consisting of 0.5 M Tris·HCl, 10% SDS, 30% glycerol, 0.2% ␤-mercaptoethanol, and 0.012% bromophenol blue, and boiled for 5 min. Protein (25 g) was separated on 7.5% or 10% SDS-PAGE gels and subsequently transferred to polyvinylidene difluoride membranes. Wet polyvinylidene difluoride membranes were blocked for 1 h at room temperature with TBS-Tween 20 and 5% nonfat milk (except for STIM2, which was incubated with PBS-casein) and incubated overnight at 4°C with primary antibodies specific for STIM1 (1:1,000, Cell Signaling No. 4916), STIM2 (1:1,000, Cell Signaling No. 4917), Orai1 (1:1,000, ProSci No. 4281), mitofusin 1 (Mnf1; 1:100, Santa Cruz Biotechnology), mitofusin 2 (Mfn2; 1:500, Abcam), dynaminrelated protein 1 (DRP-1, 1:1,000, Fisher Thermo Scientific), calsequestrin (1:5,000, Abcam No. 3516), and ER stress-specific antibodies (Cell Signaling No. 9956) for binding immunoglobulin protein/78 kDa glucose-regulated protein (BiP/GRP78; 1:1,000) and C/EBP homologous protein (CHOP; 1:1,000), inositol-requiring enzyme 1␣ (IRE1␣; 1:500), and protein disulfide isomerase (PDI; 1:1,000), after which membranes were washed in TBS-Tween 20. Membranes were incubated with the appropriate horseradish peroxidase-conjugated secondary antibodies for 2 h at 4°C. Blots were exposed to enhanced chemiluminescence detection, and images were obtained using autoradiograph film. Expression was normalized to the loading control GAPDH (1:5,000, Santa Cruz Biotechnology) in whole heart tissue and ␤-actin (1:1,000, Abcam) in cardiomyocytes.
Statistical analyses. Statistical significance was calculated using a two-way repeated-measure ANOVA, followed by a Bonferroni post hoc test or a Student's t-test, as appropriate, using GraphPad Prism 4. P values of Ͻ0.05 were considered significant. Data are presented as means Ϯ SE. All experiments comprise at least 3 to 4 mice per experimental manipulation. Densitometry of Western blots, quantification of cardiac fibrosis and collagen deposition, and quantification of mitochondrial size and number were performed using NIH ImageJ software.
RESULTS
To confirm deletion of STIM1 from cardiac tissue, we quantified STIM1 protein levels in both whole heart and isolated adult cardiomyocytes from 20-wk-old control and cr STIM1-KO mice. In whole heart tissue there was approximately a 20% reduction in total STIM1 protein expression in the cr STIM1-KO group compared with control (Fig. 1A) ; however, in cardiomyocytes isolated from cr STIM1-KO mice, STIM1 was virtually undetectable with a Ͼ90% reduction in its expression (Fig. 1B) . These data clearly demonstrate the successful deletion of STIM1 in cardiomyocytes from cr STIM1-KO mice. The modest reduction in STIM1 in the whole heart reinforces the notion that STIM1 protein levels are relatively low in adult cardiomyocytes, relative to their levels in noncardiomyocyte cells such as smooth muscle cells, endothelial cells, and fibroblasts. Furthermore, to establish whether cardiac-specific deletion of STIM1 resulted in any compensa-tory changes in other known SOCE proteins, we analyzed STIM2 and Orai1 levels in control and cr STIM1-KO cardiomyocytes and found no differences in expression between genotypes (Fig. 1C) . In addition, analysis of STIM1 expression in skeletal muscle revealed no differences between control and cr STIM1-KO groups, confirming that the changes in STIM1 are cardiac-specific (data not shown). Since calsequestrin is responsible for buffering ER/SR Ca 2ϩ levels, we examined levels of calsequestrin in cardiomyocytes isolated from 20-wkold control and cr STIM1-KO and found no significant difference between the genotypes (Fig. 1D) .
cr STIM1-KO mice were born within the expected Mendelian frequency and survive into adulthood with no obvious physical differences or changes in body weight. Unbiased gene array analyses on whole heart tissue from 12-wk-old male mice using the Illumina mouse WG-6 2.0 expression bead chip revealed only 15 genes that were differentially expressed between the two genotypes, suggesting that STIM1 deletion did not result in major adaptive/compensatory changes in the heart (Fig. 1E) . Interestingly, there were significant increases in atrial natriuretic peptide, brain natriuretic peptide, and ␣-skeletal actin in cr STIM1-KO versus control, which are characteristic of cardiac stress responses.
It has been proposed that one role for STIM1 is to ensure that ER/SR Ca 2ϩ levels are maintained at levels sufficient for appropriate protein folding and processing (10, 12) ; consequently, the lack of STIM1 could affect ER/SR Ca 2ϩ levels, leading to increased ER stress that may promote cardiac dysfunction. Therefore, we quantified the levels of ER chaperone proteins (IRE1␣, CHOP, BiP/GRP78, and PDI) in hearts (Fig. 2) . Figure 2 shows that at 12 wk, there was a significant increase in both CHOP and PDI levels in the cr STIM1-KO group. At 20 wk, CHOP and PDI remained elevated, whereas BiP/GRP78 was significantly reduced. By 36 wk, CHOP and PDI were still increased, whereas BiP/GRP78 remained depressed and IRE1␣ was significantly increased in cr STIM1-KO versus control. We also observed the same expression profiles for BiP, PDI, and CHOP in cardiomyocytes isolated from 20-wk control and cr STIM1-KO mice (Fig. 2C) . Analyses of these same proteins in skeletal muscle show no differences between control and cr STIM1-KO groups, confirming that the changes in ER stress are cardiac-specific (data not shown).
There is growing appreciation of the importance of cross talk between ER/SR and mitochondria (8) . Moreover, STIM1-deficient fibroblasts are reported to have altered mitochondrial function (14) ; therefore, we examined mitochondria morphology with transmission electron microscopy in 20-wk control and cr STIM1-KO mice. In Fig. 3 , we show that at 20 wk of age, cr STIM1-KO mice exhibit pronounced ER/SR dilatation consistent with a disruption of the close ER-mitochondria association. In addition, mitochondria from cr STIM1-KO showed heterogeneity in both size and number, resulting in increased numbers of smaller mitochondria, which were abnormally distributed throughout the tissue. We also observed that the mitochondria from cr STIM1-KO mice exhibited disruptions in cristae associated with mitochondrial fragmentation and increased focal vacuolization.
In light of the changes in mitochondrial morphology in cr STIM1-KO hearts, we quantified the levels the mitochondrial fission proteins FIS1 and DRP-1 and the mitochondrial fusion proteins Mfn1, Mfn2 and optic atrophy 1. We found that there was a significant increase in DRP-1 coupled with a significant reduction in Mfn2 levels in 20-wk cr STIM1-KO, with no change in Mfn1 expression (Fig. 3D ). There were also no differences in FIS1 or optic atrophy 1 between groups (data not shown). These results are consistent with an increase in mitochondrial fission in cr STIM1-KO hearts and could be a contributing factor to the reduction in mitochondrial size and the increase in mitochondrial number we observe.
To determine whether the lack of STIM1 had any adverse effects on cardiac function, serial echocardiography was performed in cr STIM1-KO and control littermate mice every 4 wk, from 12 to 36 wk of age (Fig. 4) . From 12 to 20 wk of age, there were no differences in cardiac function with respect to genotype; however, as shown in Fig. 4B , from 20 to 36 wk of age there was a progressive decline in ejection fraction in the cr STIM1-KO mice. Representative M-mode echo images at 12 and 36 wk as shown in Fig. 4A highlight the marked LV dilatation in the cr STIM1-KO mice at 36 wk, which is supported by the increase in LV volume (Fig. 4C) and decrease in ejection fraction (Fig. 4B) . Although there was also a signifi- cant reduction in LV wall thickness between control and cr STIM1-KO, this difference was due to a significant increase in LV wall thickness in the controls between 20 and 36 wk (Fig. 4D) , possibly reflecting a lack of active cardiac growth in the cr STIM1-KO. In addition, there were no differences in LV mass or in heart weight-to-tibia length ratio between groups (data not shown). The increase in LV volume and difference in wall thickness in cr STIM1-KO mice was also evident in tissue sections from 36-wk animals (Fig. 4E) , characteristic of the presence of a dilated cardiomyopathy. High-magnification analysis of histological sections revealed the presence of an inflammatory infiltrate and cardiac fibrosis in cr STIM1-KO at 20 wk, which progressively worsened by 36 wk and was not present in control hearts (Fig. 4F) . Kaplan-Meier survival curve analysis (Fig. 4G) demonstrates that cr STIM1-KO mice begin to die at 40 wk of age and that over 60% of cr STIM1-KO die before 50 wk of age versus control mice, which exhibit no death throughout the duration of this time course (P Ͻ 0.0001).
It has been reported that ␣-MHC-cre mice exhibit agedependent decline in cardiac function (4); therefore, we performed serial echos on a cohort of ␣-MHC-cre and wild-type mice. Using two-way repeated-measure ANOVA, unlike the differences observed between cr STIM1-KO and control mice, we found by 36 wk of age there were no significant differences in ejection fraction, LV volume, or LV wall thickness between ␣-MHC-cre and wild-type mice (data not shown). In addition, we have found that at 12 wk, unlike our cr STIM1-KO mice, there was no significant difference in the expression of ER stress markers between ␣-MHC-cre and wild-type mice (data not shown), confirming that induction of ER stress is cr STIM1-KO specific. We did not observe any additional adverse effects of cre-recombinase in the ␣-MHC-cre mice; moreover, unlike the cr STIM1-KO mice, we did not observe a dramatic decrease in survival in ␣-MHC-cre between 40 and 50 wk of age (data not shown).
DISCUSSION
STIM1 was first identified in 1996 as a single-pass ER membrane protein with unknown function; however, in 2005, it was recognized as a required component of SOCE, and since then its role in regulating SOCE has been extensively examined, particularly in nonexcitable cells. It is also increasingly apparent that STIM1 has functions that are independent of SOCE, including regulation of ARC channels (36) and maintenance of ER/SR function (11) . While there has been a growing body of evidence demonstrating that STIM1 is present in cardiomyocytes (19, 22, 37, 44) , particularly as a mediator of cardiac hypertrophy (13, 17, 22, 38) , the physiological role of STIM1 in the adult heart remains poorly understood. We have demonstrated for the first time that STIM1 plays an essential role in maintaining cardiomyocyte homeostasis. Specifically, we have shown that a Ͼ90% reduction in STIM1 expression in cardiomyocytes resulted in increased ER stress and changes in mitochondrial morphology consistent with increased mitochondrial fission that were associated with increased mortality, impaired LV function, and the development of a dilated cardiomyopathy.
The primary focus of STIM1 studies in the heart have been on the role of STIM1 in regulating hypertrophic signaling; however, the fact that STIM1 is evolutionarily highly conserved and is reported to be present in all eukaryotic cells (6) strongly suggests that it also plays an important homeostatic role. Earlier studies had reported that cardiomyocyte STIM1 protein levels decline from the embryonic to the adult heart, only to increase in response to pressure overload (17, 22) . These observations raised the possibility that STIM1 might play an important role in early development of the heart and that like many stress-related proteins, it reemerges in the adult heart subjected to increased hemodynamic stress. However, if this were indeed the case, it would be anticipated that cr STIM1-KO would either be embryonically lethal or lead to severe phenotype in young animals. It is clear that this is not the case since cr STIM1-KO mice are born with the normal Mendelian frequency and survive into young adulthood with no overt phenotype. Indeed, the fact that there are no gross morphological or functional differences between cr STIM1-KO and control hearts up to 20 wk of age indicates that STIM1 is likely unnecessary for normal cardiac development and function. On the other hand, the rapid development of a dilated cardiomyopathy between 20 and 36 wk and significant mortality starting around 40 wk of age in the cr STIM1-KO group strongly suggests that STIM1 is required for maintaining normal cardiomyocyte homeostasis in the adult heart.
One indication of the potential importance of STIM1 in adult cardiomyocytes was evident in the gene array analyses where despite relatively minor differences between cr STIM1-KO and control groups, there were significant increases in brain natriuretic peptide and atrial natriuretic peptide, indicative of an early stress response. Furthermore, at 20 wk of age, even though functionally there were no differences between groups, there were increased inflammatory infiltrate and cardiac fibrosis in cr STIM1-KO hearts, indicative of additional cardiomyocyte stress and injury. While much of the focus on the role of STIM1 as a key mediator of SOCE and Ca 2ϩ signaling, it has also been suggested that STIM1 may play a critical role in regulating ER/SR function to ensure appropriate folding and processing of proteins (37) . This is supported by the fact that as early as 12 wk of age, there is a significant elevation in CHOP and PDI proteins in cr STIM1-KO hearts, which persists up to 36 wk of age. Interestingly, BiP/GRP78 protein is normal at 12 wk but is markedly reduced at 20 wk and remains depressed through 36 wk. The reduction in BiP/GRP78 protein levels is somewhat surprising since it is typically increased in response to acute ER stress and is responsible for binding to misfolded proteins to prevent aggregation, as well as the activation of CHOP. The lack of STIM1, however, likely represents a more chronic or sustained ER stress, and as such additional studies are required to understand the mechanism(s) contributing to the lower levels of BiP/GRP78. Nevertheless, these results are consistent with other reports indicating that STIM1 may mediate ER remodeling (11) , as well as associate with several additional ER chaperone proteins such as stanniocalcin 2 (42) and the ER oxidoreductase ERp57 (32) .
There is increasing evidence to show that there is a close association between ER/SR and mitochondria (8, 40) and that the progression of ER stress can lead to impaired mitochondrial function (2, 3) . Interestingly, Henke et al. (14) reported that mouse embryonic fibroblasts lacking STIM1 exhibited abnormal mitochondrial function and morphology. These observations are consistent with our observations of altered mitochondrial morphology and disorganization in cr STIM1-KO hearts. Moreover, the changes in Mfn2 and DRP-1 seen here are indicative of a shift toward mitochondrial fission, which could account for the decrease in mitochondrial size and increased number of mitochondria observed in the cr STIM1-KO hearts. It should be noted that Mfn2 rather than Mfn1 has been shown to play a key role in mitochondrial ER/SR tethering (7) and may also regulate trafficking of STIM1 to the plasma membrane (35) ; consequently, the decrease in Mfn2 in the cr STIM1-KO hearts could be a contributing factor to the changes in mitochondrial morphology. While the mechanism underlying the decrease in Mfn2 in response to the loss of STIM1 remains to be determined, this observation underscores earlier reports indicating an interrelationship between Mfn2 and STIM1.
Cardiomyocytes are regularly exposed to an extracellular neurohormonal milleu, which includes the IP 3 -generating agonists, such as angiotensin II and endothelin, both of which are known to stimulate SOCE (29) . It is possible, therefore, that in the setting of the cr STIM1-KO heart that the adverse effects we observe are due in part to the activation of IP 3 receptor (IP 3 R) in the ER/SR in the absence of functional STIM1. If this indeed the case, then continued activation of IP 3 R could result in a prolonged reduction in ER/SR Ca 2ϩ levels, normally sensed by STIM1, which may contribute to the observed induction of ER stress we observe since a reduction in ER/SR Ca 2ϩ is known to induce ER stress (10, 12) . It should also be noted that in addition to SOCE, STIM1 has been reported to regulate arachidonate-regulated Ca 2ϩ (ARC) channels a store-independent Ca 2ϩ entry pathway (36); consequently, a lack of STIM1 may also impair this Ca 2ϩ entry pathway. However, since the function of ARC channels in the heart remains unclear, future studies are needed to determine the impact of STIM1 deletion on ARC channel activity in isolated cardiomyocytes.
Our observation that STIM1 deficiency leads to dilated cardiomyopathy is supported by reports in the zebrafish, where inactivation of the Orai1 ortholog leads to heart failure and impaired mechanosignal transduction (39) . In addition, Horton et al. (15) have shown that mice deficient in Orai1 develop a dilated cardiomyopathy that was associated with reduced survival without any evidence of cardiac hypertrophy. Humans lacking either STIM1 or Orai1 suffer from severe immunodeficiency and die at an early age from related complications; thus the effects on the heart would not be apparent. Consequently, the potential role of STIM1 in mediating cardiovascular disease in humans remains to be determined. However, it is worth noting that in a recent study, STIM1 polymorphisms were linked to increased risk for coronary artery dilatation (16) . Although this study was performed in patients with Kawasaki disease, it raises the possibility that changes in STIM1 may also be associated with other cardiovascular pathologies and therefore needs to be further investigated. It is also of note that in mice, diabetes resulted in decreased STIM1 protein and ER Ca 2ϩ levels in endothelial cells (9), and we have previously reported that hypertrophic signaling is impaired in cardiomyocytes from diabetic mice (24, 31) . It is possible therefore that impaired STIM1 function could contribute to the increase risk of heart failure in diabetes. Interestingly, we have recently shown that increased modification of proteins by O-linked N-acetylglucosamine, which occurs in diabetes, also attenuated STIM1 function and SOCE (44) .
The sustained expression of cre-recombinase in cardiomyocytes has been implicated in the development of impaired cardiac function. While this cannot be completely ruled out as a contributing factor in these studies, the fact that we did not see a decline in function in ␣-MHC-cre mice similar to cr STIM1-KO mice, would suggest this is not the case. In addition, the fact that there was no evidence of increased ER stress in 12 wk old in hearts from ␣-MHC-cre mice further supports the fact that these effects are specific for the lack of STIM1. However, this could be further confirmed using inducible, cardiomyocyte-specific STIM1-KO models, alternatively small interfering RNA approaches to chronically knockdown STIM1 as described by Hulot et al. (17) could be particularly valuable in this regard as they avoid the complications that can be associated with the different inducible KO models.
In conclusion, we have shown that the absence of STIM1 in cardiomyocytes is associated with ER stress as early as 12 wk of age as well as significant alterations in mitochondrial morphology consistent with an imbalance between mitochondrial fission and fusion and ultimately the development of a dilated cardiomyopathy and decreased life span. These findings are of particular importance, since the physiological role of STIM1 has been largely ignored in the heart. Clearly, much more needs to be done to fully understand the role of STIM1 in the heart, particularly including studies on cardiomyocyte function and Ca 2ϩ handling at the single cell level; nevertheless, it is clear that this ER/SR Ca 2ϩ -sensing protein is required for cardiomyocyte homeostasis and that may represent a novel link between ER/SR and mitochondrial function.
